|
2026 Journal Article From historical dosing to precision dosing: Modernising tobramycin monitoring in people with cystic fibrosisJohnson, Ellie, Williams, Michael, Henderson, Daniel, Riddles, Timothy, Reid, David, Smith, Daniel, Burke, Andrew and Evans, Ieuan Edward Shepherd (2026). From historical dosing to precision dosing: Modernising tobramycin monitoring in people with cystic fibrosis. European Journal of Clinical Pharmacology, 82 (11) 271. doi: 10.1007/s00228-026-04205-5 |
|
2026 Journal Article Desensitisation protocol for ethambutol in the treatment of <i>Mycobacterium avium</i> complex pulmonary diseaseDenby, George, Holt, Michael, Wilson, Malcolm, Grey, Victoria, Burke, Andrew, Thomson, Rachel and Evans, Ieuan Edward Shepherd (2026). Desensitisation protocol for ethambutol in the treatment of Mycobacterium avium complex pulmonary disease. European Journal of Clinical Microbiology & Infectious Diseases. doi: 10.1007/s10096-026-05702-2 |
|
2026 Journal Article Outcomes of non-tuberculous mycobacterial infection of the bone, joint and soft tissue: a seven-year multicentre retrospective studyLane, Angus, Morris, Arthur, Jain, Nikita, Isler, Burcu, Vemuri, Kanthi, Sinclair, Holly, Gunning, Earlleen, Thomson, Rachel, Henderson, Andrew, Burke, Andrew, Simos, Peter, Grey, Victoria, Mausolf, Magdalena, Garnham, Katherine, Ballard, Emma, Britton, Sumudu and Stewart, Adam (2026). Outcomes of non-tuberculous mycobacterial infection of the bone, joint and soft tissue: a seven-year multicentre retrospective study. Infection, 1-9. doi: 10.1007/s15010-026-02988-4 |
|
2026 Journal Article Invasive fungal infections in heart transplants: a 10‐year, single centre retrospective cohort study from Subtropical AustraliaLane, Angus, Hay, Karen, McNamara, John, Chaudhuri, Alex, Burke, Andrew, Horvath, Robert, Bayat, Maryam Khorramshahi and Vemuri, Kanthi (2026). Invasive fungal infections in heart transplants: a 10‐year, single centre retrospective cohort study from Subtropical Australia. Transplant Infectious Disease e70315, e70315-e70315. doi: 10.1111/tid.70315 |
|
2026 Journal Article Selective rapid growing mycobacterium media improves non-tuberculous mycobacteria detection and guides clinical management in Cystic FibrosisEvans, Ieuan, Smith, Kimberley, Smith, Daniel, Burke, Andrew, Thomson, Rachel, Riddles, Timothy, Wainwright, Claire, Pandey, Sushil, Jolly, Casey, Jones, Anna, Gorman, Brian, Watson, Brooke, Bostock, Jessie, Syrmis, Melanie, Coulter, Christopher and Siebert, David (2026). Selective rapid growing mycobacterium media improves non-tuberculous mycobacteria detection and guides clinical management in Cystic Fibrosis. Scientific Reports. doi: 10.1038/s41598-026-72047-3 |
|
2026 Journal Article Duration of therapy for Pseudomonas aeruginosa bacteremia—a post hoc subgroup analysis from the BALANCE randomized controlled trialYahav, Dafna, Pinto, Ruxandra, Cook, Deborah, Davis, Joshua, Duan, Erick, Hoffman, Tomer, Lee, Todd C, McDonald, Emily G, Morpeth, Susan, Muscedere, John, Sligl, Wendy, Wuerz, Terence, Fowler, Robert A, Daneman, Nick, Daneman, Nick, Rishu, Asgar, Pinto, Ruxandra, Rogers, Benjamin, Shehabi, Yahya, Parke, Rachael, Cook, Deborah J, Arabi, Yaseen, Muscedere, John, Reynolds, Steven, Hall, Richard, Dwivedi, Dhiraj Bhatia, McArthur, Colin, McGuinness, Shay, Yahav, Dafna ... Sia, Ying Tung (2026). Duration of Therapy for Pseudomonas aeruginosa Bacteremia—A Post Hoc Subgroup Analysis From the BALANCE Randomized Controlled Trial. Clinical Infectious Diseases, 83 (1), 41-47. doi: 10.1093/cid/ciag144 |
|
2026 Journal Article Cerebrospinal fluid concentrations of bedaquiline, pretomanid, and linezolid during curative treatment of fluoroquinolone-resistant pre–extensively drug-resistant tuberculous meningitisTramontana, Adrian Robert, Burke, Andrew, Globan, Maria, McWhinney, Brett, Bloch, Aaron E, Smith, Benjamin J, Denholm, Justin T, Wright, Connor James and Molton, James S (2026). Cerebrospinal Fluid Concentrations of Bedaquiline, Pretomanid, and Linezolid During Curative Treatment of Fluoroquinolone-Resistant Pre–Extensively Drug-Resistant Tuberculous Meningitis. Open Forum Infectious Diseases, 13 (7) ofag445, 7. doi: 10.1093/ofid/ofag445 |
|
2026 Journal Article Cutaneous Mycobacterium haemophilum infection in an immunosuppressed host: a case report of diagnostic considerations and microbiologic confirmationLane, Angus, Godbolt, Amanda, Morton, Sarah, Wiseby, Heather, Menon, Vivek, Coulter, Chris, Pandey, Sushil and Burke, Andrew (2026). Cutaneous Mycobacterium haemophilum Infection in an Immunosuppressed Host: A Case Report of Diagnostic Considerations and Microbiologic Confirmation. Clinical Case Reports, 14 (7) e73131. doi: 10.1002/ccr3.73131 |
|
2026 Journal Article Non-antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis – A systematic reviewBurke, Andrew, Jahnke, Nikki, Smith, Sherie, Smyth, Alan R, Stewart, Iain, Tillman, Laura and Nick, Jerry A (2026). Non-antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis – A systematic review. Journal of Cystic Fibrosis, 25 (2), 248-256. doi: 10.1016/j.jcf.2025.12.014 |
|
2026 Other Outputs The Pharmacokinetics & Pharmacodynamics of Antimycobacterial Drugs in People with Cystic Fibrosis and Drug-Resistant Tuberculosis InfectionBurke, Andrew (2026). The Pharmacokinetics & Pharmacodynamics of Antimycobacterial Drugs in People with Cystic Fibrosis and Drug-Resistant Tuberculosis Infection. PhD Thesis, UQ Centre for Clinical Research, The University of Queensland. doi: 10.14264/9518e78 |
|
2026 Journal Article Treatment outcomes and safety of clofazimine in nontuberculous mycobacterial pulmonary disease (NTM-PD)Kang, Shaun J. W., Watt, Adrian, Wilson, Malcolm R., Eather, Geoffrey W., Baird, Timothy, Evans, Ieuan E. S., Burke, Andrew J. and Thomson, Rachel M. (2026). Treatment outcomes and safety of clofazimine in nontuberculous mycobacterial pulmonary disease (NTM-PD). Mycobacteria, 2 (1) 1. doi: 10.1186/s44350-026-00012-1 |
|
2026 Journal Article A successful lung transplantation in a patient with active coronavirus disease 2019: a case reportDivithotawela, Chandima, Lee, Zhenhui Shawn, Hopkins, Peter Mark Anthony, Burke, Andrew and Fiene, Andreas (2026). A successful lung transplantation in a patient with active coronavirus disease 2019: a case report. Transplantation Proceedings, 58 (2), 378-380. doi: 10.1016/j.transproceed.2025.12.016 |
|
2025 Journal Article Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor: now is not the time to lower the guardEvans, Ieuan Edward Shepherd, Smith, Daniel, Henderson, Daniel, Riddles, Timothy, Masel, Philip, Moore, Vanessa, Burke, Andrew J., Thomson, Rachel M. and Reid, David W. (2025). Non-tuberculous mycobacterial infection in cystic fibrosis before and after initiation of elexacaftor/tezacaftor/ivacaftor: now is not the time to lower the guard. BMJ Open Respiratory Research, 12 (1) e003204, 1-9. doi: 10.1136/bmjresp-2025-003204 |
|
2025 Journal Article In vitro efficacy of sulbactam/durlobactam combined with β-lactam antibiotics in Australian Mycobacterium abscessus isolatesPatterson-Fahy, Kirby, Carter, Robyn, Bell, Scott C., Evans, Ieuan E. S., Burke, Andrew John and Thomson, Rachel M. (2025). In vitro efficacy of sulbactam/durlobactam combined with β-lactam antibiotics in Australian Mycobacterium abscessus isolates. Journal of Antimicrobial Chemotherapy, 81 (1) dkaf441, 1-9. doi: 10.1093/jac/dkaf441 |
|
2025 Conference Publication Development of quantitative CT image analysis for NTM lung disease interventionsMakani, Punitkumar, Mollica, Federico, Bonte, Merlijn, Burke, Andrew, Hicks, Daniel, Thomson, Rachel, Wainwright, Claire, Tiddens, Harm and Caudri, Daan (2025). Development of quantitative CT image analysis for NTM lung disease interventions. European-Respiratory-Society Congress (ERS), Amsterdam Netherlands, Sep 27-Oct 01, 2025. SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. doi: 10.1183/13993003.congress-2025.PA3971 |
|
2025 Journal Article Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trialJong, Tiffany, Baird, Timothy, Barr, Helen Louise, Bell, Scott, Bigirumurame, Theophile, Brady, Kara, Burke, Andrew, Byrnes, Joshua, Caudri, Daan, Clark, Julia E., Coin, Lachlan J.M., Goh, Felicia, Grimwood, Keith, Hicks, Daniel, Jayawardana, Kaushala, Joshi, Sri, Lee, Katherine, Qvist, Tavs, Reid, David, Rice, Megan, Roberts, Jason A., Rogers, Geraint, Shackleton, Claire, Sly, Peter D., Smyth, Alan R., Stevens, Luke, Stockwell, Rebecca, Tarique, Abdullah, Taylor, Steven ... Wainwright, Claire (2025). Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trial. BMJ Open, 15 (9) e096188, 1-16. doi: 10.1136/bmjopen-2024-096188 |
|
2025 Journal Article Evaluation of the stability of tigecycline in elastomeric infusion devices used for outpatient parenteral antimicrobial therapyWolie, Zenaw T., Unwin, Sean, Burke, Andrew, Won, Hayoung, Wallis, Steven C., Seaton, R Andrew, Gilchrist, Mark, Roberts, Jason A. and Sime, Fekade B. (2025). Evaluation of the stability of tigecycline in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy. JAC - Antimicrobial Resistance, 7 (3) dlaf074, dlaf074. doi: 10.1093/jacamr/dlaf074 |
|
2025 Conference Publication Adverse events related to study drugs in finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT) trialWainwright, C., Hicks, D., Rice, M., Jong, T., Gailer, N., Joshi, S., Wang, X., Burke, A., Thomson, R., Grimwood, K., Bell, S. and Clark, J. (2025). Adverse events related to study drugs in finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT) trial. 48th European Cystic Fibrosis Conference, Milan, Italy, 4-7 June 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jcf.2025.03.118 |
|
2025 Conference Publication Prevalence of nausea and vomiting and anti-emetic use in the tinding the optimal regimen for Mycobacterium abscessus treatment (Format) trialWainwright, C., Hicks, D., Rice, M., Jong, T., Joshi, S., Wang, X., Burke, A., Thomson, R., Grimwood, K., Bell, S. and Clark, J. (2025). Prevalence of nausea and vomiting and anti-emetic use in the tinding the optimal regimen for Mycobacterium abscessus treatment (Format) trial. 48th European Cystic Fibrosis Conference, Milan, Italy, 4-7 June 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jcf.2025.03.119 |
|
2025 Conference Publication Prevalence of Nausea and Vomiting and Anti-emetic Use in the Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (FORMaT) TrialThomson, R., Hicks, D., Rice, M., Jong, T., Joshi, S., Wang, X., Burke, A.J., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2025). Prevalence of Nausea and Vomiting and Anti-emetic Use in the Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (FORMaT) Trial. ATS International Conference, San Francisco, CA United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a7277 |
